G1 Therapeutics Provides First Quarter 2020 Corporate and Financial Update

    NEXT STORY
    Guardant Health to Participate in the BofA Securities 2020 Healthcare Conference
    PREV STORY
    Cytokinetics Reports First Quarter 2020 Financial Results
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Agios to Present Data From the Phase 3 ClarIDHy Study of TIBSOVO® in Previously Treated IDH1 Mutant Cholangiocarcinoma in Presidential Symposium at ESMO

    author_avatar
    NASDAQ Market News

    Rhythm Pharmaceuticals Announces Appointment of David Meeker, M.D., as Chief Executive Officer

    author_avatar
    NASDAQ Market News

    electroCore Announces First Quarter Financial Results

    author_avatar
    NASDAQ Market News